Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy characterized by late-stage diagnosis, resistance to conventional chemotherapy, and a dismal 5-year survival rate of approximately 12 %. These challenges underscore the urgent need for more ... ...

请注册登录后继续浏览